<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04173091</url>
  </required_header>
  <id_info>
    <org_study_id>TRuE012013</org_study_id>
    <nct_id>NCT04173091</nct_id>
  </id_info>
  <brief_title>Risk Stratification in Severe Treatment-naive, Tricuspid Regurgitation</brief_title>
  <acronym>TRuE</acronym>
  <official_title>Risk Stratification in Patients With Severe Tricuspid Regurgitation: Insights From the TRicuspid Regurgitation rEgistry (TRuE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This registry is aimed to characterize patients with severe tricuspid regurgitation for the
      purpose of patient selection for interventional treatment and identify factors related to
      adverse outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2013</start_date>
  <completion_date type="Anticipated">December 30, 2023</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>1 year</time_frame>
    <description>Mortality due to all causes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>5 years</time_frame>
    <description>Mortality due to all causes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>10 years</time_frame>
    <description>Mortality due to all causes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular mortality</measure>
    <time_frame>1 year</time_frame>
    <description>Mortality due to cardiovascular causes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular mortality</measure>
    <time_frame>5 years</time_frame>
    <description>Mortality due to cardiovascular causes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular mortality</measure>
    <time_frame>10 years</time_frame>
    <description>Mortality due to cardiovascular causes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of hospitalizations</measure>
    <time_frame>1 year</time_frame>
    <description>Number of hospitalizations due to right heart failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of hospitalizations</measure>
    <time_frame>2 years</time_frame>
    <description>Number of hospitalizations due to right heart failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of hospitalizations</measure>
    <time_frame>5 years</time_frame>
    <description>Number of hospitalizations due to right heart failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of hospitalizations</measure>
    <time_frame>10 years</time_frame>
    <description>Number of hospitalizations due to right heart failure</description>
  </secondary_outcome>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Functional Tricuspid Regurgitation</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>No Intervention</intervention_name>
    <description>No Intervention planed</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with severe functional tricuspid regurgitation diagnosed echocardiographically.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Severe functional tricuspid regurgitation

        Exclusion Criteria:

        prior surgery or congenital heart diseases with involvement of the tricuspid valve
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Brunilda Alushi</name>
      <address>
        <city>Berlin</city>
        <zip>12200</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brunilda Alushi, MD, PhD</last_name>
      <email>brunilda.alushi@charite.de</email>
    </contact>
    <investigator>
      <last_name>Alexander Lauten, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brunilda Alushi, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Contilia Heart and Vascular Centre</name>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Department of Internal Medicine and Cardiology, Heart Centre Leipzig</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philipp Lurz, MD</last_name>
      <email>philipp.lurz@medizin.uni-leipzig.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>German Heart Centre</name>
      <address>
        <city>Munich</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erjon Xhepa, MD, PhD</last_name>
      <email>xhepa@dhm.mhn.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rabin Medical Centre</name>
      <address>
        <city>Tel Aviv</city>
        <state>Petah Tikva</state>
        <zip>49100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ran Kornowski, MD</last_name>
      <email>ran.kornowski@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>November 16, 2019</study_first_submitted>
  <study_first_submitted_qc>November 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 21, 2019</study_first_posted>
  <last_update_submitted>March 26, 2020</last_update_submitted>
  <last_update_submitted_qc>March 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Alexander Lauten</investigator_full_name>
    <investigator_title>Professor, Head of Cardiac catheterization Laboratory</investigator_title>
  </responsible_party>
  <keyword>tricuspid regurgitation, tricuspid valve, percutaneous treatment, right ventricle</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tricuspid Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

